Novartis 2. Juni 2026 ASCO26: Celcuity's drug halves risk of disease progression, death versus Novartis' Piqray in PIK3CA-mutant breast cancer - FirstWord Pharma
Endpoints News 2. Juni 2026 #ASCO26: Celcuity plans another FDA filing after positive breast cancer readout
GE HealthCare 2. Juni 2026 GE HealthCare Unveils 4D Dynamic PET Imaging Software at SNMMI Conference - diagnosticimaging.com
Endpoints News 2. Juni 2026 Fulcrum ends sickle cell ambitions following regulatory feedback, will seek exit
Boston Scientific 2. Juni 2026 FRACTURE IDE Success Adds Clinical Support To Boston Scientific Valuation Case - Yahoo Finance
Moderna 2. Juni 2026 ASCO: Moderna’s mRNA-based melanoma vaccine shows ‘encouraging’ 5-year survival - BioSpace
Endpoints News 2. Juni 2026 Cancer cases weigh down Abivax’s Phase 3 maintenance data in ulcerative colitis
Thermo Fisher 2. Juni 2026 Thermo Fisher Scientific vs Mettler-Toledo International: Which Stock Could Rally? - Trefis
Abbott 2. Juni 2026 ASCO26: Abbott demonstrates MRD test benefit in TNBC recurrence - Medical Device Network